Friday, February 05, 2016 7:00:39 AM
This was 100% wrong:
"I'm sure you would agree that the License Agreement with TheraCour is one of the critical foundational agreements of the Corporation. And not only does the Exhibit List in the 10-K filed in September of 2015 reflect the above but ALL EIGHT of the previous 10-K filings included those same statements.
Unfortunately an investor interested in reviewing those basic agreements....agreements that are important enough for us to continue to dissect their meaning for years....won't find them on "Form 10-SB, filed with the Securities Commission on November 14, 2006" or appended to any of its 3 amendments."
The original Amended License Agreement and the one amendment to it are right where the company says they are:
"Incorporated by reference to the Company’s registration statement on Form 10-SB, filed with the Securities Commission on November 14, 2006, as amended."
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_ex10-6.htm
http://www.sec.gov/Archives/edgar/data/1379006/000114036107001282/ex10_11.htm
The THERACOUR-NANOVIRICIDES ADDITIONAL LICENSE AGREEMENT is referenced in the 10-K as having been executed on 2/25/10 and shouldn't have been hard for me to find....it was added in an Exhibit to the 10-Q filed on 3/18/10.
http://www.sec.gov/Archives/edgar/data/1379006/000114036110012749/ex10_1.htm
As noted, I had been able to find all three documents previously.
Again, no excuses. I am sorry.
To my knowledge the original License Agreement ("On May 12, 2005, the Company entered into a Material License Agreement") was never filed.
It's morally wrong to allow a sucker to keep his money.......Cuthbert J. Twillie
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM